The likely mortality benefit from pre-optimisation of high risk surgical patients depends on the baseline risk of death. The baseline risk estimated from the control groups of studies of pre-optimisation may not reflect the risk in other institutions. We determined the 28-day mortality of 'high risk' adult surgical patients in our institution by performing a retrospective cohort study of 554 patients undergoing major or ultra-major general or vascular surgery lasting more than two hours. Patients were identified as being high risk based on the presence of risk factors used in previous studies of pre-optimisation. The 28-day mortality (95% CI) was 0% for patients with no risk factors and 2.3 (0.8 to 3.7)% for patients with at least one risk factor. These data indicate that the risk of death amongst high risk surgical patients may vary considerably between institutions.
A number of single-centre studies have demonstrated that mortality amongst 'high risk' surgical patients can be reduced by preoperative optimisation [1] [2] [3] [4] . This involves preoperative admission to an intensive care unit (ICU) and administration of fluids and inotropes to increase oxygen delivery to a pre-determined level. Such an approach may place a considerable strain on intensive care resources as it has been estimated that 7% of patients undergoing surgery fall into the high risk category 1 . Pre-optimisation of emergency surgical patients is made more complex by the need to balance the putative benefits of pre-optimisation against the risks of delayed surgery. The ability to plan admission to the ICU and the timing of the operation make pre-optimisation of elective patients more attractive. One of the criticisms of the studies of patients undergoing elective surgery is that the mortality in the control group seemed surprisingly high, ranging from 17 to 50% 3, 4 . Other studies have demonstrated a lower mortality but used different criteria to identify high risk patients (Table 1) .
Clearly the potential benefit of preoperative optimisation is related to the patients' baseline risk with a higher potential benefit for patients at higher risk. Unfortunately the risk of death for high risk surgical patients has not been clearly established. Although data from the control groups of optimisation studies suggest the risk is high, estimates based on these data may be unreliable. It is unlikely that these studies included all eligible patients: the authors did not describe a method of systematically identifying all eligible patients, nor did they give any indication of what proportion of eligible patients were recruited 1, 3, 4 . As a result the data from the control groups of these studies may have been distorted by referral filter bias 9 . For example it is conceivable that only those patients with more severe disease were brought to the attention of the study investigators. Similarly the incidence of high risk surgical patients has not been systematically studied, making it difficult to assess the impact of adopting a policy of routine pre-optimisation on intensive care resources.
In order to determine the risk of death of high risk surgical patients undergoing elective surgery and to determine the incidence of high risk surgical patients, we carried out a retrospective study of all patients undergoing major general surgery in a university teaching hospital over a period of one year.
METHODS
The study was approved by the Clinical Research Ethics Committee of The Chinese University of Hong Kong, which waived the need for patient consent in view of the purely observational nature of the study. It was a retrospective study of all adult (>18 years) patients undergoing major elective general or vascular surgery at a tertiary referral university teaching hospital during the year 2001. The major endpoint was mortality at the 28th postoperative day with a minor endpoint of hospital mortality.
Patients were identified from a manual search of the relevant operating theatre registers. Only those patients who were recorded as having undergone a major or ultra-major general surgical or vascular procedure lasting more than two hours were included in the study. Classification of procedures as ultra-major or major was based on the classification published by the Hong Kong Government. The presence or absence of criteria used to identify patients as high risk in previous studies were recorded ( Table 2) , based solely on the diagnoses documented in the patients' notes. In addition, demographic data, unplanned admission to intensive care and operative procedure were noted. All these data were extracted from the patients' notes by two investigators (CDG, SJR). Disagreements were settled by consensus. Mortality data were obtained by a third investigator (Pl) from the hospital computer system, supplemented where necessary by telephone follow-up. If a patient underwent more than one procedure during 2001, only data related to the first procedure were included in the study.
Statistical analysis was carried out using the Statistical Package for the Social Sciences for Windows 14.0 (SPSS Inc, Chicago, Il, U.S.A.). Proportions were compared using Fisher's exact test, medians were compared using the Kruskal-Wallis test and means using Student's unpaired t test. A value of P <0.05 was considered significant.
RESUlTS
A total of 871 patients underwent a major or ultra-major general surgical or vascular procedure. Of these, 575 underwent procedures lasting more than two hours. All notes necessary to complete data collection were available for 554 patients (96.3%). The overall 28 day mortality for these three cohorts were 14/871 (1.6%), 11/575 (1.9%) and 11/554 (2.0%). Further data analysis was restricted to the 554 patients who underwent procedures lasting more than two hours and for whom all necessary records could be obtained. The procedures undergone by these patients and the mortality associated with each of those procedures is given in Table 3 . The median ASA score was 2 (interquartile range 2 to 2). Patients with more risk factors were significantly more likely to be electively admitted to the ICU for postoperative care (2.7%, 10%, 11.6%, 14.5% for zero, one, two and three or more risk factors respectively, P <0.001). The morbidity and mortality associated with the presence of zero to three or more risk factors is given in Table 4 . The overall 28-day mortality (95% CI) of patients with at least one risk factor was 2.3% (1.4 to 4.3%). Overall hospital mortality (95% CI) in this cohort was 3.7% (1.9 to 5.4%). Both hospital mortality and postoperative hospital length of stay were significantly associated with number of risk factors. Amongst those who died in hospital the median time to death was 14 (interquartile range 12 to 31) days after the index operation. Of the risk factors studied only extensive ablative surgery for malignancy and congestive cardiac failure were significantly associated with mortality ( Table 2) .
Of the 554 patients, 79% (95% CI 75.3 to 82.1%) had at least one risk factor.
DISCUSSION
Our data demonstrate that the mortality of high risk surgical patients may vary considerably from institution to institution. In our hospital the 28-day mortality amongst the 437 patients with at least one risk factor undergoing major or ultra-major elective surgery lasting more than two hours was only 2.3% which is considerably lower than that reported by previous studies using similar high risk criteria 3, 4 .
There are several possible reasons for this variability. First, the absence of precise definitions for the risk factors is likely to result in variable interpretation of the presence or absence of risk factors. For example the definition of chronic renal insufficiency used by doctors in our hospital may have varied from that used by lobo et al 3 and Wilson et al 4 . Neither group of authors gave precise definitions of the factors used in their studies to identify high risk patients. Second, the variability may be due to referral filter bias. It is possible that the patients entered into the lobo et al 3 
and
Wilson et al 4 studies were a subgroup of patients with more severe disease. Unfortunately neither group of investigators gave details of the number of eligible patients who were not recruited and therefore it is not possible to assess to what extent the study patients were a selected subgroup. There is, however, indirect evidence of referral filter bias. In Wilson et al's study the vast majority of patients had more than two risk factors, suggesting that it was predominantly those with more severe disease that were recruited 4 . Conversely it is possible that the low mortality in our hospital reflects another form of referral filter bias with higher risk patients not being admitted for major surgery. Third, as a result of our single-centre study design, we are unable to exclude the possibility that the low mortality in our high risk patients is due to some other characteristic specific to our institution. Fourth, some of the putative risk factors for mortality may be poorly specific or even nonpredictive in which case the overall mortality will vary with case mix. Although most have been identified to predict adverse outcomes in previous studies, not all have been well established as risk The American Heart Association list of major and intermediate patient risk factors for perioperative myocardial infaction, heart failure or death includes ischaemic heart disease, heart failure, significant arrhythmias, severe valvular heart disease, diabetes and renal insufficiency. Vascular surgery and prolonged surgery associated with large fluid shifts and/or blood loss are considered high risk procedures 10 . Of the risk factors used by lobo et al and Wilson et al 3 , only age (odds ratio 1.015) and chronic obstructive airways disease (odds ratio 1.235) were amongst the 10 most important risk factors for postoperative morbidity in a study of 87,078 patients undergoing major non-cardiac surgery 11 . Even when combining mortality with severe morbidity, only ischaemic heart disease, chronic arrhythmia, congestive cardiac failure, hypertension and chronic obstructive pulmonary disease were amongst the predictors of severe adverse outcome in 17,201 patients undergoing general anaesthesia for surgery 12 . The odds ratios for severe adverse outcome associated with these factors were all ≤2.25.
A recent systematic review of preoperative pulmonary risk stratification for non-cardiothoracic surgery concluded that there was good evidence of an association between the following factors and postoperative pulmonary complications: advanced age, ASA class 2 or higher, functional dependence, chronic obstructive pulmonary disease and congestive cardiac failure. Procedurerelated risk factors were general anaesthesia, aortic aneurysm repair and non-resective thoracic, abdominal, head and neck, emergency or neurosurgery 13 . In this context it should be noted that although our data provide little support for the utility of most of the factors, they do not exclude the possibility that these factors identify patients at higher risk. Due to a combination of a low overall mortality and a relatively low prevalence of many of the risk factors, the power of the study to demonstrate a difference in mortality in those with and without any given risk factor was low.
Our findings suggest that routine preoperative optimisation of all high risk surgical patients, as defined by the inclusion criteria of previous studies 3, 4 , is not appropriate in our institution. The benefit achieved by such an approach is dependent on the baseline risk and thus would be considerably lower in our institution than the benefit demonstrated by these studies. Using the risk reduction demonstrated by lobo et al 3 
and Wilson et al 4 and
the 28 day mortality demonstrated in our study, the number needed to treat in order to save one life would be between 127 and 311. In lobo et al and Wilson et al's studies the number needed to treat was three and seven respectively 3, 4 . In addition, a recent meta-analysis suggested that the benefit of haemodynamic optimisation is restricted to groups with a baseline risk of death >20% 14 . This conclusion is supported by Sandham et al's randomised controlled trial which showed no benefit from preoperative optimisation in patients with a baseline mortality risk of approximately 7% 8 .
Based on our data the resource implications of routine preoperative optimisation of all high risk surgical patients would be considerable. Of the 554 patients undergoing major or ultra-major surgery, 79% (437 patients) would be classified as high risk. Preoperative optimisation of all high risk patients would therefore have resulted in the use of an additional 437 extra ICU bed-days in a year. More accurate identification of high risk patients would not only make it more likely that those who undergo preoperative optimisation benefit from the intervention, but would also reduce the number of patients requiring it, thus improving the cost-benefit ratio.
Although there was a substantial hospital mortality rate (9.1%) amongst those with three or more risk factors, the potential to reduce this mortality appears limited, given the low 28day mortality rate in this group (4.5%). It seems unlikely that pre-optimisation will impact on deaths occurring more than 28 days later. Simchen et al's study of the effect of intensive care on the mortality of critically ill patients suggests that the predominant benefit from admission to ICU is in reducing deaths in the first few days following deterioration and that thereafter survival curves tend to converge 15 .
The major weakness of our study was that it was a single centre retrospective chart review without strict definitions of risk factors. As a result it is possible that our findings are not applicable to other institutions. Nevertheless our results illustrate the difficulty of identifying a truly high risk group using the current loosely defined criteria. We believe that the next step in investigating the potential of preoperative optimisation to reduce mortality is to accurately identify high risk patients, precisely define risk factors and then identify the subgroup of these patients that benefit from pre-optimisation. In terms of defining risk factors the definitions used in the guidelines on cardiovascular and pulmonary risk may be useful 10, 13 . In the meantime we would suggest that clinicians determine the baseline risk of high risk patients in their own hospitals before deciding whether to adopt a policy of preoperative optimisation.
In summary, using the criteria used in previous studies of preoperative optimisation to identify patients, the overall 28-day mortality for high risk general surgical patients in our institution was only 2.3%. This suggests that the actual risk of death for high risk patients may vary considerably from hospital to hospital. Based on our findings, we recommend that clinicians establish the actual risk of 'high risk' patients in their own institutions before adopting routine preoperative optimisation for these patients.
